Skip to main content

Table 3 Comparison between the studied groups regarding IHC expression of prohibitin

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

Parameters Group F (P)
Control Benign Borderline Malignant  
Intensity (Mean ± SD) 2.2 ± 0.6 2.0 ± 0.0 2.6 d ±0.5 3.0 d ±0.0 0.001*
% (Mean ± SD) 69.3 ± 10.2 66.3 ± 16.0 85.6 d ±9.0 96.3 d ±3.9 0.001*
Score (Mean ± SD) 147.8 ± 43.5 132.5 ± 31.9 226.7 d ±64.4 288.8 d ±11.8 0.001*
  1. F One Way ANOVA, d significantly different group (s), *P < 0.05 (significant)